NOV 14, 2018 4:00 PM PST

Rapid Tumor Targeting

WRITTEN BY: Nicholas Breehl

Cancer, a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, continues to be one of the most devastating diseases. If the spread is not controlled, it can result in death. To treat cancer, several therapies have come to light. Researchers at the University of California Irvine have developed a technology that promotes the use of adoptive T cell therapy by reducing development time, increasing specificity and reducing the cost associated with its development.

About 1.7 million new cancer cases are expected to be diagnosed in 2018. Around 609,640 Americans are expected to die of cancer in 2018, equating to approximately 1,670 deaths per day. Adoptive T cell transfer, specifically T cell receptor T cell therapy, holds promise for cancer immunotherapy with encouraging clinical results. The real issue with TCR T cell therapy, however, is that finding a TCR T cell clone is a tedious, time-consuming, and costly task.

Adoptive T cell therapy involves the isolation and ex vivo (outside of the body) of tumor-specific T cells to achieve a greater number of T cells. The tumor-specific T cells are then infused back into cancer patients in an attempt to kill cancer cells.  There are many forms of adoptive T cell therapy being used for cancer treatment; culturing tumor infiltrating lymphocytes or TIL, isolating and expanding one particular T cell or clone, and even using T cells that have been engineered to recognize and attack tumors potently. 

"This technology is particularly exciting because it dismantles major challenges in cancer treatments," said Zhao, an associate professor of pharmaceutical sciences who is affiliated with the Chao Family Comprehensive Center and the Sue & Bill Gross Stem Cell Research Center. "This use of droplet microfluidics screening significantly reduces the cost of making new cancer immunotherapies that are associated with less systemic side effects than standard chemotherapy drugs, and vastly speeds up the timeframe for treatment."

One giant hurdle for adoptive T cell therapy is the identification of particular T cell receptors that will match to the cancer antigen in a pool of millions of other antigens. It can take up to one year to locate a match in which time the cost can amount to around half a million dollars.

Zhao and his research team created a technology that incorporated oil-water droplets allowing cancer cells to match with individual T cells. The TCRs that bind with the cancer cell’s antigens can be sorted and identified within only a few days.

Zhao and his fellow researchers at the University of California Irvine hope their technology will aid in the further developing adoptive T cell therapies for cancer patients.

Sources: Lab on a Chip, Science Daily, American Cancer Society, University of Washington, YouTube

About the Author
You May Also Like
JUL 20, 2019
Cardiology
JUL 20, 2019
Strep Throat Can Lead To Heart Complications
Rheumatic fever (RF) is a complication resulting from untreated strep throat. Caused by group A streptococcal infection, rheumatic fever was once the numbe...
AUG 23, 2019
Immunology
AUG 23, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
SEP 07, 2019
Immunology
SEP 07, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
NOV 20, 2019
Health & Medicine
NOV 20, 2019
Could your bedding make you sick?
Do you use duvets or pillows filled with goose or duck feathers? While indeed cozy, doctors have issued a new warning related to feather filled bedding cal...
FEB 10, 2020
Immunology
FEB 10, 2020
Measles infections can give the immune system amnesia
The immune system detects the presence of invading microbes that it recognizes from previous infections, and initiates a full-blown immune response. New re...
Loading Comments...